1.5 mg semaglutide to tirzepatide

1.5 mg semaglutide to tirzepatide Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are VivioMD GLP-1 Program Overview 2026:

Name: 1.5 mg semaglutide to tirzepatide Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are VivioMD GLP-1 Program Overview 2026:
Brand: zentrummensch.at
SKU: 13915012460
Price: 21.01 USD
Availability: InStock
Rating: 4.8514 (17 reviews)

SKU: 13915012460

4.9

USD21.01 USD55.01

Pay in 4 interest-free payments of $5.25 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 31 - Sep 5

Description

We are not an online company

If you notice any cloudiness, particles, or a change in color, do not use it

Compounded GLP-1 scripts arent directly tracked, but public disclosures let us triangulate a credible range

While peptides certainly have their benefits for specific populations, the benefits are overstated for healthy individuals using peptides off-label, says board-certified physician Michael Genovese, M.D

Introduction Glucagon-like peptide-1 receptor agonists (GLP-1 RA) enhance glucose-dependent insulin secretion and exhibit other antihyperglycemic actions